ALERT OF THE WEEK- Stop Monsanto’s Genetically Engineered Wheat

wheatMonsanto and the biotech bullies are once again moving to tighten their grip on the world’s food supply. Genetically engineered (GE) varieties now account for 70-90% of all conventional (non-organic) corn, soybeans, cotton, and canola grown in the U.S. Joining the growing menu of unlabeled and untested gene-spliced Frankenfoods, genetically engineered sugar (derived from GE sugar beets) hit store shelves in 2008. Now it appears that the most controversial crop of them all, Monsanto’s GE wheat, is not far behind, at least if industry gets its way. Given that wheat is such a major global crop and essential ingredient in bread, breakfast cereals, pasta and other everyday foods, the force-feeding of unlabeled GE wheat on the public would represent a major conquest for Monsanto and the biotech industry.

Although Monsanto withdrew their applications to the U.S. and Canadian governments for approval of genetically engineered wheat in 2004 because of tremendous pressure from the OCA and hundreds of our allied public interest groups and farmers (as well as pressure from large food companies such as General Mills), it looks like we’re in for another round of battle.

Wheat industry groups in the United States, Canada and Australia announced on May 14, 2009, they would work toward the objective of “synchronized commercialization of biotech traits in the wheat crop.” For the sake of the Earth and public health, we must stop them.

LEARN MORE AND TAKE ACTION

U.S. Physicians Announce Founding Of American Academy Of Cannabinoid Medicine

Santa Barbara, CA: A coalition of US physicians and researchers has founded a new organization dedicated to promoting ethical standards in therapeutic cannabis treatment.

“The American Academy of Cannabinoid Medicine … is a professional medical organization dedicated to the clinical and scientific understanding of the endoccannabinoid system and the therapeutic application of cannabis and cannabinoids,” the group states in a press release.

It continues: “The Academy serves as an authoritative information source for doctors, state medical boards and the media on the medical application and research related to the clinical use of cannabis and cannabinoids. We are dedicated to educating physicians about the clinical therapeutic usefulness of cannabis to relieve symptoms of the myriad of diseases that respond to this class of medications.”

Members of the organization “will promote high medical ethical and practice standards in the approval and recommendation of cannabis for medicinal purposes.” According to the organization’s website, the AACM has “developed certifying practice standards and guidelines for practicing physicians who recommend and approve the medicinal use of cannabis acting within state law.”

“Our mission is to foster the highest standards in the practice of cannabinoid medicine,” the website states.

For more information about the American Academy of Cannabinoid Medicine, please visit: http://aacmsite.org.